Large pericardial effusion as a complication in adults undergoing SCT

Por Norkin, M, Ratanatharathorn, V, Ayash, L, Abidi, MH, Al-Kadhimi, Z, Lum, LG, Uberti, JP
Publicado em 2010

Multiple infusions of CD20-targeted T cells and low-dose IL-2 after SCT for high-risk non-Hodgkin’s lymphoma: A pilot study

Por Lum, LG, Thakur, A, Pray, C, Kouttab, N, Abedi, M, Deol, A, Colaiace, WM, Rathore, R
Publicado em 2013

Long-term follow up of patients proceeding to transplant using plerixafor mobilized stem cells and incidence of secondary myelodysplastic syndrome/AML

Por Deol, A, Abrams, J, Masood, A, Al-Kadhimi, Z, Abidi, MH, Ayash, L, Lum, LG, Ratanatharathorn, V, Uberti, JP
Publicado em 2013

Low-dose antithymocyte globulin enhanced the efficacy of tacrolimus and mycophenolate for GVHD prophylaxis in recipients of unrelated SCT

Por Ratanatharathorn, V, Deol, A, Ayash, L, Cronin, S, Bhutani, D, Lum, LG, Abidi, M, Ventimiglia, M, Mellert, K, Uberti, JP
Publicado no Bone Marrow Transplant (2014)